All Supplement articles
View all stories of the same content type.
-
SupplementHormone replacement therapy (HRT) shortage: switching to Femoston® (estradiol/dydrogesterone) from an alternative combination oral or transdermal HRT
Information for healthcare professionals only. This supplement has been commissioned and funded by Mylan and developed in partnership with Guidelines . Please see bottom of page for full disclaimer. Hormone replacement therapy (HRT) shortage: switching to Femoston ® (estradiol / dydrogesterone) from an alternative ...
-
Supplement
Asthma guidance update
This Guidelines supplement has been commissioned and funded by Mylan and developed in partnership with Guidelines . The content on page 3 was commissioned by Mylan and Mylan has carried out full medical review and approval to ensure compliance. See page 2 for full disclaimer. Prescribing information can ...
-
Supplement
The importance of the progestogenic component of hormone replacement therapy in women with a uterus
Information intended for healthcare professionals only. Guidelines approached Mylan for an educational grant to support the production of this supplement. Mylan has had no influence over the selection of the authos or the content of the supplement and has reviewed it for technical accuracy and ...
-
Supplement
Type 2 diabetes: an overview of the SIGN guideline on pharmacological management of glycaemic control
Production of this Guidelines supplement has been funded by an educational grant from Napp Pharmaceuticals Limited. The grant included an honorarium for the author. Napp Pharmaceuticals Limited has reviewed the supplement for technical accuracy and to ensure compliance with regulations. Napp
